Buscar
Mostrando ítems 21-30 de 37
Arginase-1 A New Immunohistochemical Marker of Hepatocytes and Hepatocellular Neoplasms
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
The distinction of hepatocellular carcinoma (HCC) from metastatic tumor in the liver often presents a diagnostic challenge that carries significant impact on prognostication and therapy. The number of diagnostically useful ...
Possible association between Carney complex and multiple endocrine neoplasia type 1 phenotypes
(Sociedade Brasileira de Endocrinologia e Metabologia, 2008-11-01)
Complexo de Carney (CNC) e neoplasia endócrina múltipla tipo 1 (MEN1) são formas de neoplasias endócrinas múltiplas de herança autossômica dominante. O diagnóstico do CNC ocorre quando dois critérios maiores (lentiginose, ...
Lack of mutation in exon 10 of p53 gene in thyroid tumors
(Sociedad Médica de Santiago, 2004)
Possible association between Carney complex and multiple endocrine neoplasia type 1 phenotypes
(Sociedade Brasileira de Endocrinologia e Metabologia, 2008-11-01)
Complexo de Carney (CNC) e neoplasia endócrina múltipla tipo 1 (MEN1) são formas de neoplasias endócrinas múltiplas de herança autossômica dominante. O diagnóstico do CNC ocorre quando dois critérios maiores (lentiginose, ...
High-pressure phase diagram of the drug mitotane in compressed and/or supercritical CO2
(New York, 2010)
This work provides experimental phase diagram of mitotane, a drug used in the chemotherapy treatment of adrenocortical carcinoma, in compressed and/or supercritical CO2. The synthetic-static method in a high-pressure ...
High-pressure phase diagram of the drug mitotane in compressed and/or supercritical CO(2)
(ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2010)
This work provides experimental phase diagram of mitotane, a drug used in the chemotherapy treatment of adrenocortical carcinoma, in compressed and/or supercritical CO(2). The synthetic-static method in a high-pressure ...
Possible association between Carney complex and multiple endocrine neoplasia type 1 phenotypes
(Sociedade Brasileira de Endocrinologia e Metabologia, 2014)
TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes
(Springer Verlag (Germany), 2017)